Persistent homology derived radiomic feature predicts survival in non-small cell lung cancer patients treated with SBRT

medRxiv (Cold Spring Harbor Laboratory)(2022)

引用 0|浏览3
暂无评分
摘要
Abstract Introduction Improved survival prediction and risk stratification in non-small cell lung cancer (NSCLC) would lead to better prognosis counseling, adjuvant therapy selection, and clinical trial design. We propose the PHOM (persistent homology) score, the radiomic quantification of solid tumor topology, as a solution. Methods Patients diagnosed with stage I or II NSCLC primarily treated with stereotactic body radiation therapy (SBRT) were selected ( n = 554). The PHOM score was calculated on each patient’s pre-treatment CT scan (10/2008 to 11/2019). PHOM score, age, sex, stage, Karnofsky Performance Status (KPS), Charlson-Comorbidity Index (CCI), and post-SBRT chemotherapy were predictors in the Cox proportional hazards models for overall and cancer-specific survival. Patients were split into high and low PHOM score groups compared using Kaplan-Meier curves for overall survival and cumulative incidence curves for cause specific death. Finally, we generated a validated nomogram to predict overall survival, publicly available at https://eashwarsoma.shinyapps.io/LungCancerTDATest/ . Results PHOM score was a significant predictor for overall survival (HR: 1.17, 95% CI: 1.07−1.28) and was the only significant predictor for cancer-specific survival (1.31, 95% CI: 1.11−1.56) in the multivariable Cox model. The median survival for the high PHOM group was 29.2 months (95% CI: 23.6−34.3), which was significantly worse compared to the low PHOM group (45.4 months, 95% CI: 40.1−51.8, p < 0.001). The high PHOM group had a significantly greater chance of cancer-specific death at post treatment month 65 (0.244, 95%CI: 0.192−0.296) compared to the low PHOM group (0.171, 95% CI: 0.123−0.218, p = 0.029). Conclusions The PHOM score is associated with cancer-specific survival and predictive of overall survival. Our developed nomogram can be used to inform clinical prognosis and assist in making post-SBRT treatment considerations.
更多
查看译文
关键词
cell lung cancer,radiomic feature,cancer patients,persistent homology,non-small
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要